TPSF
PGNX

Texas Permanent School Fund’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Texas Permanent School Fund’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-73,562
Closed -$280K – 1533
2020
Q1 		$280K Buy
73,562
+14,449
+24% +$62.3K 0.01% 1374
2019
Q4 		$301K Buy
59,113
+291
+0.5% +$1.54K ﹤0.01% 1437
2019
Q3 		$297K Buy
58,822
+1,309
+2% +$6.53K ﹤0.01% 1415
2019
Q2 		$355K Buy
57,513
+110
+0.2% +$530 0.01% 1390
2019
Q1 		$266K Buy
57,403
+2,079
+4% +$9.41K ﹤0.01% 1449
2018
Q4 		$232K Buy
55,324
+2,565
+5% +$13.1K ﹤0.01% 1446
2018
Q3 		$331K Buy
52,759
+5,180
+11% +$39.8K ﹤0.01% 1434
2018
Q2 		$383K Buy
47,579
+1,059
+2% +$8.08K 0.01% 1420
2018
Q1 		$347K Sell
46,520
-980
-2% -$6.52K ﹤0.01% 1412
2017
Q4 		$283K Sell
47,500
-3,800
-7% -$23.1K ﹤0.01% 1454
2017
Q3 		$378K Buy
51,300
+28
+0.1% +$178 ﹤0.01% 1414
2017
Q2 		$348K Buy
51,272
+954
+2% +$7.04K ﹤0.01% 1420
2017
Q1 		$475K Buy
+50,318
New +$502K 0.01% 1338

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Texas Permanent School Fund's PGNX Position: Q2 2020 in Review

Texas Permanent School Fund sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 73,562 shares — an estimated $280K sold.

Texas Permanent School Fund first reported a position in PGNX in Q1 2017 and held it in 13 quarters. The position peaked at $475K in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Texas Permanent School Fund reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Texas Permanent School Fund sold 73,562 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $280K.
  • Texas Permanent School Fund first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 13 quarters.
  • Texas Permanent School Fund's Progenics Pharmaceuticals Inc position peaked at $475K in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Texas Permanent School Fund's 13F filing for Q2 2020, filed 4 Aug 2020.